The effects of a benzodiazepine receptor antagonist β-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Psychopharmacology

• Publication date

  1996-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF02246647PMID 8867876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective effects of triazolam on memory

  2005cited by this paper
• Effects of acute doses of oxiracetam in the scopolamine model of human amnesia

  2005cited by this paper
• Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood

  2005cited by this paper
• A comparison of the effects of scopolamine and diazepam on working memory

  2005cited by this paper
• Human studies on the benzodiazepine receptor antagonist β-carboline ZK 93 426: antagonism of lormetazepam's psychotropic effects

  2004cited by this paper
• Qualitative analysis of scopolamine-induced amnesia

  2004cited by this paper
• The effects of scopolamine on working memory in healthy young volunteers

  2004cited by this paper
• Human studies on the benzodiazepine receptor antagonist β-carboline ZK 93 426: preliminary observations on psychotropic activity

  2004cited by this paper
• Amnestic effects of lormetazepam and their reversal by the benzodiazepine antagonist Ro 15-1788

  2004cited by this paper
• Effects of scopolamine and nicotine on human rapid information processing performance

  2004cited by this paper
• What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia?

  1995cited by this paper
• Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing

  1995cited by this paper
• Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humans.

  1995cited by this paper
• Double dissociation between the effects of muscarinic antagonists and benzodiazepine receptor agonists on the acquisition and retention of passive avoidance

  1995cited by this paper
• The efficacy of cholinergic drugs in patients with Alzheimer's disease—focus on the aminoacridines

  1995cited by this paper
• Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer type.

  1994cited by this paper
• A Double FDG/PET Study of the Effects of Scopolamine in Older Adults

  1994cited by this paper
• Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography.

  1994cited by this paper
• Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers.

  1994cited by this paper
• Cholinergic blockade and human information processing: are we asking the right questions?

  1994cited by this paper
• Neurotransmission--the link integrating Alzheimer research?

  1994cited by this paper
• Nicotine and tetrahydroaminoacradine: Evidence for improved attention in patients with dementia of the Alzheimer type

  1994cited by this paper
• Cholinergic control of cognitive resources.

  1993cited by this paper
• Role of GABA during the multiple consolidation of memory

  1993cited by this paper
• Inhibition of hippocampal acetylcholine release by benzodiazepines: antagonism by flumazenil.

  1993cited by this paper
• A double‐blind, placebo‐controlled study of the effects of eptastigmine on scopolamine‐induced cognitive deficits in healthy male subjects

  1993cited by this paper
• Scopolamine-induced amnesia in humans: lack of effects of the benzodiazepine receptor antagonist β-carboline ZK 93426

  1992cited by this paper
• Continuous attention: rationale and discriminant validation of a test designed for use in psychopharmacology

  1992cited by this paper
• Bidirectional Activity of Benzodiazepine-receptor Ligands in Cognitive Functions in Humans

  1991cited by this paper
• Absence of Priming Coupled with Substantially Preserved Recognition in Lorazepam-Induced Amnesia

  1989cited by this paper
• Cognitive enhancing properties of antagonist β-carbolines: new insights into clinical research on the treatment of dementias?

  1989cited by this paper
• Effects of scopolamine on verbal memory; a retrieval or acquisition deficit?

  1989cited by this paper
• Anterograde and retrograde amnesia after lormetazepam and flunitrazepam.

  1988cited by this paper
• Beta-carbolines as tools in memory research: human data with the beta-carboline ZK 93426.

  1988cited by this paper
• Treatment strategies for senile dementia: antagonist beta-carbolines.

  1988cited by this paper
• β -Carbolines as Tools in Memory Research: Human Data with the β -Carboline ZK 93426

  1988cited by this paper
• Cholinergic Drugs and Human Cognitive Performance

  1988cited by this paper
• Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.

  1987cited by this paper
• Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.

  1986cited by this paper
• Models of Memory Dysfunctions

  1985cited by this paper
• Human information-processing: some effects of methylphenidate, age, and scopolamine.

  1984cited by this paper
• The Effects of Intravenous Diazepam and Hyoscine upon Human Memory

  1984cited by this paper
• The effects of intravenous diazepam and hyoscine upon recognition memory.

  1984cited by this paper
• SEVERE ANXIETY INDUCED BY FG 7142, A β-CARBOLINE LIGAND FOR BENZODIAZEPINE RECEPTORS

  1983cited by this paper
• A memory test for longitudinal measurement of mild to moderate deficits.

  1980cited by this paper
• Effects of Cholinergic Agents on Human Learning and Memory

  1979cited by this paper
• STUDIES ON HUMAN MEMORY THE INTERACTIONS OF DIAZEPAM, SCOPOLAMINE AND PHYSOSTIGMINE

  1978cited by this paper
• Studies on human memory: The interactions of diazepam, scopolamine, and physostigmine

  1977cited by this paper
• Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory

  1975cited by this paper
• Human memory and the cholinergic system. A relationship to aging?

  1974cited by this paper
• Evaluating storage, retention, and retrieval in disordered memory and learning

  1974cited by this paper
• The Cholinergic Synapse and the Site of Memory

  1971cited by this paper
• The central effects of scopolamine in man.

  1971cited by this paper
• A 3 min reasoning test based on grammatical transformation

  1968cited by this paper
• Der Pauli-Test : Anweisung zur Sachgemässen Durchführung, Auswertung und Anwendung des Kraepelinschen Arbeitsversuches

  1961cited by this paper
• The Antecedents of Cancer

  1867cited by this paper

• The effect of scopolamine on memory and attention: a systematic review and meta-analysis

  2025cites this paper
• Insights on benzodiazepines' potential in Alzheimer's disease.

  2023cites this paper
• Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects

  2022cites this paper
• Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man

  2021cites this paper
• The GABAergic system as a therapeutic target for Alzheimer's disease

  2018influential citation
• Neurochemical and neuropharmacological characterization of ASP2905, a novel potent selective inhibitor of the potassium channel KCNH3

  2017cites this paper
• Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time task

  2017cites this paper
• Memory deficits in aging and neurological diseases.

  2014cites this paper
• Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test.

  2013cites this paper
• Muscarinic M1 receptor modulation of cognition using a translational approach : relevance for dementia and schizophrenia

  2012cites this paper
• Human pharmacology of current and new treatments for schizophrenia

  2012cites this paper
• Drug targets for cognitive enhancement in neuropsychiatric disorders.

  2011cites this paper
• Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings

  2011cites this paper
• Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.

  2011cites this paper
• Pharmacodynamic Evaluation: CNS

  2011cites this paper
• Part I. Unified pharmacophore protein models of the benzodiazepine receptor subtypes. Part II. Subtype selective ligands for alpha5 Gaba(A) /BZ receptors

  2011cites this paper
• The Revival of Scopolamine Reversal for the Assessment of Cognition-Enhancing Drugs

  2009cites this paper
• Blocking GABA-A receptors in the medial septum enhances hippocampal acetylcholine release and behavior in a rat model of diencephalic amnesia.

  2009cites this paper
• RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

  2008influential citation
• PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.

  2008cites this paper
• The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates

  2008influential citation
• Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.

  2008cites this paper
• From the Behavioral Pharmacology of Beta-Carbolines to Seizures, Anxiety, and Memory

  2007cites this paper
• The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice.

  2007cites this paper
• Human cognition assessment in drug research.

  2006cites this paper
• An inverse agonist selective for α5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze

  2006cites this paper
• Sedation and memory: studies with a histamine H-1 receptor antagonist

  2006cites this paper
• Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys.

  2006cites this paper
• Chlordiazepoxide interactions with scopolamine and dizocilpine: novel cooperative and antagonistic effects on spatial learning.

  2005cites this paper
• The dopaminergic system and human spatial working memory : a behavioural, eletrophysiological and cerebral blood flow investigation

  2005cites this paper
• Does alcohol affect memory for emotional and non-emotional experiences in different ways?

  2004cites this paper
• Prefrontal cortical modulation of posterior parietal acetylcholine release: a study of glutamatergic and cholinergic mechanisms

  2004cites this paper
• Dissociation between mesocortical dopamine release and fear‐related behaviours in two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions

  2003cites this paper
• Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats

  2003cites this paper
• Human models as tools in the development of psychotropic drugs

  2002cites this paper
• Objective markers of drug effects on brain function from recordings of scalp potential in healthy volunteers

  2002cites this paper
• Effects of lovastatin and pravastatin on cognitive function in military aircrew.

  2001cites this paper
• Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory.

  2001cites this paper
• The pharmacology of human working memory.

  2001cites this paper
• Psychotogenic properties of benzodiazepine receptor inverse agonists

  2001cites this paper
• The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females

  2000cites this paper
• State-dependent effects of alcohol on explicit memory: the role of semantic associations

  2000cites this paper
• Hemispheric lateralisation in a manual-verbal task combination: the role of modality and gender.

  2000cites this paper
• Pharmacological models in Alzheimer's disease research

  2000cites this paper
• Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function.

  2000cites this paper
• Lifelong estrogen exposure and cognitive performance in elderly women.

  1999cites this paper
• Cognition enhancement strategies by ion channel modulation of neurotransmission.

  1999cites this paper
• Scopolamine slows the orienting of attention in primates to cued visual targets

  1999cites this paper
• Regional brain activity during shape recognition impaired by a scopolamine challenge to encoding

  1999cites this paper
• Pharmacology of sensory stimulation-evoked increases in frontal cortical acetylcholine release.

  1998cites this paper
• The effects of incentive on antisaccades: is a dopaminergic mechanism involved?

  1997cites this paper